ZA974334B - Fluorinated Vitamin D3 analogs. - Google Patents

Fluorinated Vitamin D3 analogs.

Info

Publication number
ZA974334B
ZA974334B ZA9704334A ZA974334A ZA974334B ZA 974334 B ZA974334 B ZA 974334B ZA 9704334 A ZA9704334 A ZA 9704334A ZA 974334 A ZA974334 A ZA 974334A ZA 974334 B ZA974334 B ZA 974334B
Authority
ZA
South Africa
Prior art keywords
analogs
fluorinated vitamin
fluorinated
vitamin
Prior art date
Application number
ZA9704334A
Other languages
English (en)
Inventor
Bernard Michael Hennessy
Milan Radoje Uskokovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA974334B publication Critical patent/ZA974334B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA9704334A 1996-05-23 1997-05-19 Fluorinated Vitamin D3 analogs. ZA974334B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1818796P 1996-05-23 1996-05-23

Publications (1)

Publication Number Publication Date
ZA974334B true ZA974334B (en) 1997-11-24

Family

ID=21786696

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9704334A ZA974334B (en) 1996-05-23 1997-05-19 Fluorinated Vitamin D3 analogs.

Country Status (30)

Country Link
US (1) US5888994A (fr)
EP (1) EP0808831B1 (fr)
JP (1) JP2858571B2 (fr)
KR (1) KR100237523B1 (fr)
CN (1) CN1081184C (fr)
AR (1) AR007240A1 (fr)
AT (1) ATE195514T1 (fr)
AU (1) AU720098B2 (fr)
BR (1) BR9703373A (fr)
CA (1) CA2204478C (fr)
CO (1) CO4840512A1 (fr)
CZ (1) CZ157997A3 (fr)
DE (1) DE69702812T2 (fr)
DK (1) DK0808831T3 (fr)
ES (1) ES2150719T3 (fr)
GR (1) GR3034832T3 (fr)
HR (1) HRP970274A2 (fr)
HU (1) HUP9700927A3 (fr)
IL (1) IL120842A0 (fr)
MA (1) MA24345A1 (fr)
NO (1) NO971934L (fr)
NZ (1) NZ314838A (fr)
PL (1) PL320131A1 (fr)
PT (1) PT808831E (fr)
SG (1) SG50831A1 (fr)
TR (1) TR199700418A3 (fr)
TW (1) TW374762B (fr)
UY (1) UY24563A1 (fr)
YU (1) YU19997A (fr)
ZA (1) ZA974334B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO971934L (no) * 1996-05-23 1997-11-24 Hoffmann La Roche Flourinerte vitamin D3 -analoger
EP0981523B1 (fr) 1997-05-16 2005-12-07 Woman & Infants Hospital Composes de vitamine d3 a ether cyclique et composes de 1alpha(oh)3-epi-vitamine d3, et utilisation desdits composes
AU744471B2 (en) * 1997-05-16 2002-02-21 Women & Infants Hospital 3-epi vitamin D2 compounds and uses thereof
EP1015423B1 (fr) * 1997-09-08 2003-05-02 F. Hoffmann-La Roche Ag Analogues de vitamine d 3? de 1,3-dihydroxy-20,20-dialkyle
AU3390400A (en) * 1999-03-05 2000-09-21 Johns Hopkins University, The Regulating skin appearance and composition with a fluorinated vitamin d3 analog compound
US7148211B2 (en) * 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
US20080293647A1 (en) 2004-11-12 2008-11-27 Luciano Adorini Combined Use Of Vitamin D Derivatives And Anti-Proliferative Agents For Treating Bladder Cancer
PT1993559T (pt) 2006-02-03 2016-09-26 Opko Renal Llc Tratamento da insuficiência e deficiência de vitamina d com 25-hidroxivitamina d2 e 25-hidroxivitamina d3
SI2037936T1 (sl) 2006-06-21 2014-11-28 Opko Renal, Llc Postopek zdravljenja in prepreäśevanja sekundarnega hiperparatiroidizma
CA2943032C (fr) 2007-04-25 2019-05-07 Cytochroma Inc. Compositions orales a liberation controlee comprenant des composes de vitamine d et un vehicule cireux
KR101495578B1 (ko) 2007-04-25 2015-02-25 사이토크로마 인코포레이티드 비타민 d 부족 및 결핍의 치료 방법
US11672809B2 (en) 2010-03-29 2023-06-13 Eirgen Pharma Ltd. Methods and compositions for reducing parathyroid levels
WO2012065050A1 (fr) 2010-11-12 2012-05-18 Wisconsin Alumni Research Foundation Analogues 22-haloacétoxy-homoprégnacalciférol et leurs utilisations
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 d 방출 제형
AU2015298858A1 (en) 2014-08-07 2017-03-02 Opko Ireland Global Holdings Ltd. Adjunctive therapy with 25-hydroxyvitamin D
CR20180510A (es) 2016-03-28 2019-05-15 Opko Ireland Global Holdings Ltd Método de tratamiento con vitamina d

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5039671A (en) * 1984-12-19 1991-08-13 Hoffmann-La Roche Inc. Trifluorinated-1α,25S-dihydroxy vitamin D3 compounds
US5145846A (en) * 1988-01-20 1992-09-08 Hoffmann-La Roche Inc. Vitamin D3 analogs
US4804502A (en) * 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
GB9007236D0 (en) * 1990-03-30 1990-05-30 Leo Pharm Prod Ltd Chemical compounds
GB9017890D0 (en) * 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
US5206230A (en) * 1991-06-05 1993-04-27 Daikin Industries, Ltd. Fluorine-containing vitamin D3 analogues and pharmaceutical composition containing the same
US5210237A (en) * 1991-08-27 1993-05-11 Daikin Industries, Ltd. Vitamin d3 analogues
US5200536A (en) * 1992-02-10 1993-04-06 Daikin Industries Ltd. Fluorine-containing vitamin D3 analogues
GB9206648D0 (en) * 1992-03-26 1992-05-06 Leo Pharm Prod Ltd Chemical compounds
EP0580968B1 (fr) * 1992-05-20 1996-08-28 F. Hoffmann-La Roche Ag Derivés fluorinés de la vitamine D3
CA2096105A1 (fr) * 1992-10-07 1994-04-08 Enrico Giuseppe Baggiolini (Deceased) Analogues fluores de vitamine d3
TW267161B (fr) * 1992-11-20 1996-01-01 Hoffmann La Roche
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
US5384314B1 (en) * 1994-03-11 1997-08-05 Hoffmann La Roche 1alpha-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol
NO971934L (no) * 1996-05-23 1997-11-24 Hoffmann La Roche Flourinerte vitamin D3 -analoger

Also Published As

Publication number Publication date
KR970074763A (ko) 1997-12-10
US5888994A (en) 1999-03-30
TR199700418A2 (xx) 1997-12-21
EP0808831B1 (fr) 2000-08-16
HRP970274A2 (en) 1998-04-30
GR3034832T3 (en) 2001-02-28
ES2150719T3 (es) 2000-12-01
MX9703776A (es) 1998-06-30
BR9703373A (pt) 1998-09-15
AR007240A1 (es) 1999-10-27
AU2357297A (en) 1997-11-27
CZ157997A3 (en) 1997-12-17
SG50831A1 (en) 1998-07-20
IL120842A0 (en) 1997-09-30
JP2858571B2 (ja) 1999-02-17
DK0808831T3 (da) 2001-01-02
PL320131A1 (en) 1997-11-24
KR100237523B1 (ko) 2000-01-15
MA24345A1 (fr) 1998-07-01
AU720098B2 (en) 2000-05-25
JPH1045712A (ja) 1998-02-17
CO4840512A1 (es) 1999-09-27
NO971934D0 (no) 1997-04-25
ATE195514T1 (de) 2000-09-15
NZ314838A (en) 1998-01-26
PT808831E (pt) 2000-12-29
EP0808831A2 (fr) 1997-11-26
DE69702812T2 (de) 2001-01-25
NO971934L (no) 1997-11-24
HU9700927D0 (en) 1997-07-28
CN1169425A (zh) 1998-01-07
HUP9700927A3 (en) 1999-07-28
EP0808831A3 (fr) 1999-02-03
CA2204478A1 (fr) 1997-11-23
TR199700418A3 (tr) 1997-12-21
YU19997A (sh) 1999-07-28
UY24563A1 (es) 2000-12-29
TW374762B (en) 1999-11-21
HUP9700927A2 (hu) 1998-01-28
CN1081184C (zh) 2002-03-20
CA2204478C (fr) 2006-11-21
DE69702812D1 (de) 2000-09-21

Similar Documents

Publication Publication Date Title
ZA974336B (en) Vitamin D3 analogs.
ZA974334B (en) Fluorinated Vitamin D3 analogs.
ZA976242B (en) Illudin analogs useful as antitumor agents.
EP0996458A4 (fr) Analogues de sandramycine
ZA200110487B (en) Vitamin D3 Analogs.
ZA9711567B (en) Compounds.
ZA97944B (en) N: 1 Transcoder.
ZA975861B (en) Bromotiacumicin compounds.
SG70010A1 (en) Fluorinated vitamin d3 analogs
ZA972944B (en) Novel retinoids.
ZA974332B (en) Fluorinated vitamin D3 analogs.
ZA974056B (en) New thiazolopyridines.
GB9601685D0 (en) Fluorinated compounds
SG24096A1 (en) Fluorinated vitamin D3 derivative
ZA933357B (en) Vitamin D3 fluorinated analogs
ZA9610663B (en) Wetsuit.
ZA978284B (en) Staircases.
GR2001944Y (en) Kinesthisiometer -goniometer feet.
ZA978645B (en) Lighting equipment.
ZA986155B (en) (+)-norcisapride.
SI1023263T1 (en) Novel vitamin d analogues